Home » Stocks » LRMR » Company

Larimar Therapeutics, Inc. (LRMR)

Stock Price: $10.32 USD 0.30 (2.99%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed
Larimar Therapeutics, Inc.
Country United States
Industry Biotechnology
Sector Healthcare
Employees 28

Contact Details

Address:Three Bala Plaza East. Suite 506
Bala Cynwyd, Pennsylvania 19004
United States
Phone 844 511 9056

Stock Information

Ticker Symbol LRMR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency US Dollars
CIK Code 1374690
ISIN Number US5171251003

Company Description

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases.

The company's lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare and progressive genetic disease.

Larimar Therapeutics, Inc. is headquartered in Bala Cynwyd, Pennsylvania.

Key Executives

Dr. Carole S. Ben-MaimonChief Executive Officer, President and Director
Michael CelanoChief Financial Officer
John BermanVice President of Finance and Operations
Jennifer Spokes JohanssonVice President of Regulatory Affairs and Counsel
Dr. Nancy M. RuizChief Medical Officer
Francis Michael ConwayVice President and Controller